In Vivo CAR Immune Cell Engineering Bypasses Complex Manufacturing in Early Cancer Trials
A comprehensive review highlights how in vivo CAR immune cell engineering bypasses complex ex vivo manufacturing, while navigating clinical efficacy ...
A comprehensive review highlights how in vivo CAR immune cell engineering bypasses complex ex vivo manufacturing, while navigating clinical efficacy ...
A retrospective cohort study found that combination antifungal therapies did not yield significantly different clinical outcomes compared with caspofungin or ...
A scientific review highlights how microproteins translated from previously overlooked short open reading frames regulate leukemogenesis and present novel targets ...
Severe early thrombocytopenia following CAR T-cell therapy is associated with reduced overall survival and higher relapse rates in patients with ...
A meta-analysis of 13 studies in Ethiopia found that hematological malignancies account for approximately half of pediatric cancer cases.
A retrospective study indicates that CT-derived coronary artery calcification scores show no prognostic association with overall survival or transplant complications ...
A multidisciplinary Saudi expert panel has established a consensus protocol detailing vaccination, non-pharmaceutical measures, and variant-targeted monoclonal antibody prophylaxis for ...
A scientific review highlights Musashi-2 as a context-dependent post-transcriptional organizer involved in stabilizing pathological cellular states across diverse diseases.
A retrospective ICU study of 106 patients found that chest CT patterns in Pneumocystis jirovecii pneumonia differ according to the ...
A new review synthesizes engineering strategies and early clinical findings for CAR-NK cell immunotherapy in blood cancers and solid tumors.
A UK study shows rapid whole genome sequencing cuts pediatric cancer diagnosis time from six weeks to three days while ...
A new systematic review and meta-analysis of 20 studies finds that 61 percent of cancer patients resume some anticancer treatment ...
A prospective Polish study shows that patients who develop graft-versus-host disease in the first six months after allogeneic stem cell ...
A fourteen-year Brazilian cohort study of nearly 29,000 cancer patients found hepatitis B virus seroprevalence fell from 16.5 to 9.9 ...
In a significant development in the field of oncology, researchers A. Tuerxun, Y. Yang, and X. Cai, along with their ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.